 says the exciting part of the finding is that “an inexpensive, simple test for CDX2 expression is already widely available,” although it will have to undergo prospective and randomized clinical trials before it is ready for clinicians to use with colon cancer patients.
Meanwhile, Medical News Today recently learned how a gene called Sprouty2 – known to stop tumors spreading in many types of cancer – appears to promote spread in some colorectal cancers.